Uncertainty in assessing impact of drug-drug interactions on oxycodone metabolite patterns.

DePriest, Anne Z; Puet, Brandi L; Heltsley, Rebecca; Robert, Timothy; Black, David L

DePriest, Anne Z; Puet, Brandi L; Heltsley, Rebecca; Robert, Timothy; Black, David L.

Afiliação

DePriest AZ; Aegis Sciences Corporation, Nashville, TN, USA Department of Clinical Pharmacy, University of Tennessee, Memphis, TN, USA anne.depriest@aegislabs.com.
Puet BL; Aegis Sciences Corporation, Nashville, TN, USA Department of Clinical Pharmacy, University of Tennessee, Memphis, TN, USA.
Heltsley R; Aegis Sciences Corporation, Nashville, TN, USA.
Robert T; Aegis Sciences Corporation, Nashville, TN, USA.
Black DL; Aegis Sciences Corporation, Nashville, TN, USA Vanderbilt University, Department of Pathology, Immunology, and Microbiology, Nashville, TN, USA.

J Anal Toxicol ; 38(7): 462, 2014 Sep.

Article em En | MEDLINE | ID: mdl-24986837

Assuntos

Analgésicos Opioides/urina; Morfinanos/urina; Oxicodona/urina; Oximorfona/urina; Dor/tratamento farmacológico; Feminino; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxicodona / Oximorfona / Dor / Analgésicos Opioides / Morfinanos Limite: Female / Humans / Male Idioma: En Revista: J Anal Toxicol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google